Nadunolimab

Product Description: Nadunolimab is a human monoclonal IgG1 antibody targeting IL1RAP. Nadunolimab blocks IL-1α and IL-1β signaling and triggering antibody-dependent cellular cytotoxicity. Nadunolimab can be used in research of cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Rydberg Millrud C, et, al. Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy. Cancer Immunol Immunother. 2022 Aug 29.

Molecular Weight: N/A

Compound Purity: 98.11

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99235-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99235-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK